When, how, and why a bone biopsy should be performed in patients with chronic kidney disease.
about
Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.Biomarkers Predicting Bone Turnover in the Setting of CKD.Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion.Transient Hypocalcemia in a Dialysis Patient With Paget's disease and Presumed Renal Cell CarcinomaBone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper.The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients.Miniaturized analytical instrumentation for electrochemiluminescence assays: a spectrometer and a photodiode-based device.Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism.Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.Update on the role of bone biopsy in the management of patients with CKD-MBD.Complex interplay among adiposity, insulin resistance and bone health.
P2860
Q36432849-D7F2262D-3ABD-4324-B434-BA7C00356059Q38803449-1E020BB5-C25B-4379-8CD4-AB992E71993CQ38836379-49B96227-32AD-438F-BCCF-12C9C5BC9D0BQ39254025-33600417-4D30-442B-89CB-B1DA7116BCBDQ39255870-2D5A352F-98E9-4CA4-A31D-2A8592833605Q39413414-1891B94B-C9FA-49EE-8747-8D126732F4B9Q39447041-6D3293C4-C45E-477C-A7CA-5EFAEC2127D6Q39712019-4112D256-60EA-4D77-8B39-F3CC94C170BAQ40275241-6483E375-E8B5-4AD8-BB1D-14EBC2D73EAAQ40828040-37455853-F9F2-4136-BB1F-2AB327219513Q42282597-63E33725-AAC1-4564-904B-3D47050EAEA7Q46532893-E57C53A3-70BE-4B0D-80E0-F4F108BF82FBQ47549937-AFCD83E1-2114-4469-98B6-DE5F624745F4Q47789778-9B673577-9756-4F36-81DB-7B86A1E7A1D2Q48197934-73A7C021-ADB4-42A5-8E6A-4956AEFA74D9Q50044972-8D42154B-21E5-4325-8007-F3F27AD3C0CE
P2860
When, how, and why a bone biopsy should be performed in patients with chronic kidney disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
When, how, and why a bone biop ...... s with chronic kidney disease.
@ast
When, how, and why a bone biop ...... s with chronic kidney disease.
@en
When, how, and why a bone biop ...... s with chronic kidney disease.
@nl
type
label
When, how, and why a bone biop ...... s with chronic kidney disease.
@ast
When, how, and why a bone biop ...... s with chronic kidney disease.
@en
When, how, and why a bone biop ...... s with chronic kidney disease.
@nl
prefLabel
When, how, and why a bone biop ...... s with chronic kidney disease.
@ast
When, how, and why a bone biop ...... s with chronic kidney disease.
@en
When, how, and why a bone biop ...... s with chronic kidney disease.
@nl
P2093
P1476
When, how, and why a bone biop ...... ts with chronic kidney disease
@en
P2093
Jordi Bover
Marie Christine de Vernejoul
Pablo Ureña Torres
P304
P356
10.1016/J.SEMNEPHROL.2014.09.004
P577
2014-11-01T00:00:00Z